Brighton Jones LLC Alnylam Pharmaceuticals, Inc. Transaction History

Brighton Jones LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$170.77 - $211.65 $23,224 - $28,784	136 Added 3.6%	3,912 $692,000
Q2 2023 Jul 31, 2023	BUY	$185.01 - $212.05 $4,255 - $4,877	23 Added 0.61%	3,776 $717,000
Q1 2023 May 08, 2023	BUY	$182.66 - $235.53 $685,522 - $883,944	3,753 New	3,753 $751,000
Q3 2018 Nov 07, 2018	SELL	$87.52 - $122.67 $346,316 - $485,405	-3,957 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$88.31 - $107.8 $4,150 - $5,066	-47 Reduced 1.17%	3,957 $390,000
Q1 2018 May 03, 2018	SELL	$115.92 - $148.54 $2,086 - $2,673	-18 Reduced 0.45%	4,004 $477,000
Q4 2017 Feb 08, 2018	BUY	$114.49 - $139.98 $1,259 - $1,539	11 Added 0.27%	4,022 $511,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,011	4,011 $320,000

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.